α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson's Disease Models
α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson's Disease Models
复制标题
α-突触核蛋白通过防止帕金森病模型中 Parkin 介导的 DMT1 泛素化来调节铁稳态
DOI:
10.1021/acschemneuro.0c00196
复制
发表时间:
2020-06-03
影响因子:
5
通讯作者:
Jiang, Hong
中科院分区:
文献类型:
--
作者:
Bi, Mingxia;Du, Xixun;Jiang, Hong
Iron metabolism imbalance plays a key role in the neurodegeneration of Parkinson's disease (PD), thus iron homeostasis should be tightly controlled by iron transporters. alpha-Synuclein (alpha-Syn) serves as a ferrireductase and iron-binding protein, which is supposed to be linked with iron metabolism, but little is known about how alpha-Syn affects iron homeostasis in PD. Our previous findings that up-regulation of divalent metal transporter 1 (DMT1) accounted for the nigral iron accumulation in PD raised the question whether alpha-Syn disturbed iron homeostasis by modulating DMT1 expression. Using alpha-Syn overexpressed SH-SY5Y cells and mutant human A53T alpha-Syn transgenic mice, we found that alpha-Syn could upregulate DMT1 protein levels, followed by enhanced ferrous iron influx and subsequent aggravated oxidative stress injury. Mechanistic studies identified that alpha-Syn-induced p38 mitogen-activated protein kinase (MAPK) activation phosphorylated parkin at Ser131, which inactivated parkin's E3 ubiquitin ligase activity and further reduced DMT1 ubiquitylation level. Our findings revealed that alpha-Syn affected brain iron homeostasis through modulating DMT1 protein stability and altering cellular iron uptake, which might provide direct evidence for the involvement of alpha-Syn in iron metabolism dysfunction and provide insight into PD-associated nigral iron deposition.